Dragonfly Therapeutics, Inc., a clinical stage biotechnology company developing novel immunotherapies, announced the April 13th publication of preclinical data in Cell Press's Med supporting DF6002...
Poseida Therapeutics, Inc., a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases, announced...
Ajax Therapeutics, Inc., a biopharmaceutical company applying computational chemistry and structure-based technologies to develop novel, selective small molecules for myeloproliferative neoplasms (MPNs), announced the...
Q32 Bio, a clinical stage biotechnology company developing biologic therapeutics to restore immune homeostasis, announced that the Company presented new preclinical data demonstrating the...
ReCode Therapeutics, a biopharmaceutical company powering the next wave of genetic medicines through superior delivery presented new preclinical data from the company’s inhaled mRNA-based...
